After 8 weeks of last PRRT treatment, Ga-68 DOTATATE PET/CT was done on Jan 29, 2024, and next day the report came. So some good news, some bad news, but overall I am getting improved. Waiting for my oncologist appointment next week.

IMPRESSION:
Overall mixed response with decreased size and radiotracer uptake of multiple mediastinal lymph nodes.
Innumerable osseous radiotracer avid metastatic lesions, some of which have decreased metabolic activity compared to prior, and some of which are increased in size and have increased metabolic activity compared to prior.
If clinically indicated, consider a follow-up study to ensure progressive partial resolution of the bone lesions with further increased radiotracer intensity since the prior 3/27/2023.

CHEST PET/CT IMAGES:
- Lungs: The lungs are clear. No pulmonary nodules are seen. Bibasilar atelectasis.
- Lymph nodes: Decreased size and radiotracer uptake of right hilar lymph node (series 4, image 122), with SUV max of 6.9, previously 13.4.
Pretracheal lymph node with SUV max of 2.7 (series 4, image 113), similar to prior. Prevascular lymph node (series 4, image 109), with SUV max of 3.3, previously 4.5.
- Pleural spaces: There are no pleural effusions.
- Mediastinum & Heart: The heart is normal in size. Postsurgical changes of the pericardium. No pericardial effusion.
- Chest wall: No Ga-68 DOTATATE -avid soft tissue mass.

MUSCULOSKELETAL PET/CT IMAGES:
Innumerable osseous radiotracer avid metastatic lesions, many of which have decreased uptake compared to prior.
For example, right scapular lesion with SUV max of 3.1, previously 9.9.
Increased size and radiotracer uptake of left iliac wing metastasis (series 4, image 226), with SUV max of 7.9. Increased size and radiotracer uptake of metastasis in the right aspect of the L4 vertebrae (series 4, image 199), with SUV max of 9.5, previously 8.1.